Drug or technology

Macupatide

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 2 TRIAL

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

ClinicalTrials.gov

This is a Phase 2 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.

PreliminaryMacupatide Eli Lilly and Company Obesity

Reported

Planned enrollment200

Study phasePhase 2

Primary outcome measurePercent change from baseline in body weight…

AUG 14, 2026 · PHASE 1 TRIAL

A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes

ClinicalTrials.gov

Phase 1 safety and tolerability study in a planned enrollment of 60 participants; no results posted; designed to characterize adverse events and pharmacokinetics rather than efficacy.

PreliminaryMacupatide Eli Lilly and Company Obesity

Reported

Planned enrollment60

Study phasePhase 1

Primary endpointNumber of Participants with One or More Ser…